The chimeric antigen receptor (CAR) directs T cells to target and kill specific cancer cells. Despite the success of CAR T therapy in clinics, the intracellular signaling pathways that lead to CAR T cell activation remain unclear. Using CD19 CAR as a model, we report that, similar to the endogenous T cell receptor (TCR), antigen-engagement triggers the formation of CAR microclusters that transduce downstream signaling. However, CAR microclusters do not coalesce into a stable central supramolecular activation cluster (cSMAC). Moreover, LAT, an essential scaffold protein for TCR signaling, is not required for microcluster formation, immunological synapse formation, and actin remodeling following CAR activation. Meanwhile, CAR T cells still require LAT for the normal production of the cytokine IL-2. Together, these data show that CAR T cells can bypass LAT for a subset of downstream signaling outputs, thus revealing a rewired signaling pathway as compared to native T cells.
Introduction
The development of T cells engineered with chimeric antigen receptors (CARs) has launched a new era of cell-based therapy for cancer. CAR is a synthetic single-pass transmembrane receptor that is intended to mimic the signal transducing function of the T cell receptor (TCR). CAR recognizes a tumor antigen and activates pathways leading to T cell activation. CAR-T cell therapy, as approved by FDA, has been successfully applied to treat patients with B cell cancers including acute lymphoblastic leukemia and non-Hodgkin lymphoma [1] [2] [3] . However, many patients do not respond to CAR T therapy and some suffer from severe neurotoxicity and cytokine release syndrome 4, 5 . Furthermore, there are unexplained aspects of the CAR T cell response to antigen stimulation. CARs, for example, trigger faster tyrosine phosphorylation of downstream effectors and faster cytotoxic granule release in CD8 + T cells 6 . Perhaps even more surprisingly, CAR-CD4 + T cells can kill target cells as efficiently as CAR-CD8 + T cells, although the basis of this phenomenon is not known 7 . A better understanding of the molecular mechanism of CAR signaling is needed for explaining the unique aspects of CAR T cells and could suggest new strategies for designing better CAR-T therapies targeting broad types of cancers.
Here, we sought to define the signaling pathways downstream CAR activation in both immortalized human T cell lines (Jurkat T cells) and primary human T cells. We found that, similar to TCR, CARs form near micron-sized clusters that serve as signaling platforms to transduce the activation signal from antigen engagement. However, LAT, an adaptor protein essential for TCR microcluster formation, is dispensable for the formation of CAR microclusters and CAR-induced immunological synapses. CAR also can bypass LAT to activate LAT's downstream signaling pathways leading to actin reorganization and synapse formation. Together, these data suggest that CAR T cells display a rewired signaling pathway as compared to the TCR pathway in native T cells.
Results and Discussion

CARs form microclusters upon ligand engagement
We used the 3 rd generation CD19-CAR as a model, which is activated by the CD19 molecule on the B cell surface. A transmembrane domain derived from CD8 connects the extracellular single chain variable fragment (scFv) recognizing CD19 to the intracellular domain composed of the cytoplasmic part of TCR subunit CD3, co-receptor CD28, and 4-1BB ( Figure 1A) . A GFP tag was introduced at the C-terminus to visualize CAR dynamics. GFP-tagged CAR was stably introduced into Jurkat T cells by lentiviral transduction. To stimulate these CAR-T cells, we used a supported lipid bilayer-based activation system 8 , which is compatible with high signal-to-noise imaging of the T cell plasma membrane by total internal reflection fluorescence (TIRF) microscopy.
In this system, recombinant CD19 proteins, the ligand for CAR, were attached to the supported lipid bilayers, as a surrogate for antigen-presenting cells. To facilitate cell adhesion, the supported lipid bilayer also was coated with ICAM-1, an integrin ligand ( Figure 1B) .
When CAR-T cells were plated onto the CD19-and ICAM-1-coated bilayers, CAR microclusters rapidly formed as cells spread on the supported lipid bilayer ( Figure 1C) . These CAR microclusters were enriched in phosphotyrosines, indicating that they are spots of active signaling ( Figure 1D) . In contrast, in the absence of CD19, neither microclusters nor phosphotyrosine signals were present on the T cell membranes ( Figure 1D) . These data show the CD19 binding to CAR triggers the formation of signaling-competent microclusters, which is very similar to what has been reported for pMHC-triggered TCR microclusters 9, 10 .
We then monitored the behavior of CAR microclusters in a longer term. In about one-quarter of the CAR-T cells, CAR microclusters translocated to the cell center and formed a stable disk-like structure (Figure 1E , upper panel and Movie S1), which resembles the central supramolecular activation cluster (cSMAC) 11 . However, in another quarter of cells, the CAR cSMAC initially formed but then quickly disassembled (Movie S2). The average time between cell landing and cSMAC disassembly was ~7 min. We also observed moving synapses (kinapse) in about 11% of cells (Movie S3). Most strikingly, in ~40% of cells, individual microclusters remained separated and did not form a cSMAC (Figure 1E lower panel, Movie S4). Together, these data ( Figure 1F) suggest that CARs form microclusters, but these generally do not coalesce into a stable cSMAC.
CARs can bypass LAT to form microclusters and induce immunological synapse formation
Next, we determined the molecular requirements for transducing CAR signaling. LAT, or linker for activation of T cells, is an essential adaptor for TCR signaling 12 . Deletion or mutation of LAT impairs formation of T cell microclusters 13, 14 as well as signal transduction to downstream pathways including calcium influx, MAPK activation, IL-2 production, and actin remodeling 15, 16 .
Firstly, we reconfirmed that TCR microclusters did not form in a LAT-deficient Jcam2.5 T cell line (Figure 2A, left panel) . Surprisingly, however, we found that CARs still formed microclusters in the same LAT-deficient line (Figure 2A and 2B) .
Next, we investigated whether CAR microclusters can recruit signaling components downstream of LAT. Gads is a cytosolic adaptor that is, after TCR activation, recruited to the plasma membrane by LAT. Gads bridges LAT to SLP76, which further connects the LAT microclusters to the actin polymerization machinery 9 . We found that Gads could be recruited to CAR microclusters in both the presence and absence of LAT. The amount of Gads relative to CAR recruited to membranes in LAT-deficient cells is comparable to that in the wild-type cells ( Figure 3A) . This result indicates Gads can still be recruited to CAR microclusters without LAT.
We then investigated whether LAT is required for the activation of SLP76. SLP76 is a constitutive binding partner for Gads 17 and activated SLP76 recruits Nck, an important regulator of actin assembly 18 , to LAT clusters on the membrane. To assess the activation level of membraneassociated SLP76, we performed immunofluorescence microscopy using a phospho-SLP76 antibody. We found that pSLP76 levels at the membrane were similar between the wild-type and LAT-deficient cells following CD19-dependent CAR activation ( Figure 3B ). In contrast, the level of pSLP76 was not increased by OKT3, the activating antibody for TCR, in LAT-deficient cells ( Figure 3B) . These results suggest that LAT is required for TCR-triggered, but not CAR-triggered activation of SLP76. In support of the idea that LAT is not required for Gads-SLP76-actin pathway, in LAT-deficient CAR-T cells, CAR microclusters were still robustly translocated from the periphery to the cell center (Movie S5). This result indicates that CAR engagement with CD19 induces actin polymerization-dependent retrograde flow in LAT knockout cells.
Actin polymerization also stabilizes immunological synapse formation between a T cell and an antigen-presenting cell. To test if LAT is required for CAR-T cell synapse formation, we incubated CAR-T cells with Raji B cells that express CD19. We found LAT-deficient cells can still form synapses with Raji B cells, though the efficiency is lower than the wild-type cells (Figure 3C ). This result suggests that LAT promotes but is not essential for CAR-induced immunological synapse formation. Together, these data suggest that LAT is not essential for transducing signaling from CAR to the actin polymerization pathway.
LAT is required for CAR-triggered PIP2 hydrolysis and IL-2 production
In parallel, we determined if LAT is required for PIP2 signaling following CAR activation. We used mCherry-labeled C1 domain as a reporter for diacylglycerol (DAG) 19 , the product of PIP hydrolysis. In contrast to wild-type cells, in which the C1 domain was robustly recruited to the plasma membrane upon CAR activation, C1 was not recruited in LAT-deficient cells (Figure S1A) .
Consistent with a defect in PIP hydrolysis, CAR also did not induce IL-2 secretion in LAT-deficient cells ( Figure S1B ). Together, these data suggest LAT is essential for CAR-triggered PIP2 signaling and IL-2 production in Jurkat T cells.
LAT is not required for CAR signaling in human primary T cells
Next, we sought to determine if a LAT-independent CAR signaling pathway exists in primary T cells. To do so, we knocked out the LAT gene in human primary T cells by CRISPR-based genome targeting. The LAT protein levels were reduced in the overall cell population to 12% as revealed by immunoblot analysis (Figure 4A ). CAR-GFP was then introduced into wild-type or LAT null T cells by lentiviral transduction. TIRF microscopy revealed that TCR microclusters were formed in wild-type but not LAT null cells following OKT3 engagement on planar lipid bilayers. In contrast, CAR microclusters were formed in both wild-type and LAT null cells following CD19 engagement ( Figure 4B) . Moreover, SLP76, the adaptor linking CAR to actin, was equally activated in wild-type and LAT null CAR T cells, as determined by a phospho-SLP76 antibody ( Figure 4C) . Interestingly, we also found that LAT null CAR T cells produced IL-2, though at a lower level than wild-type CAR T cells ( Figure 4D ). This result differs from that obtained with Jurkat T cells, in which IL-2 production is completely abolished in LAT-deficient cells (Figure S1B) .
The mechanism underlying this difference is unclear, potentially due to the different signaling responses between Jurkat and primary T cells 20 . Together, these data suggest that LAT is not required for CAR microcluster formation and SLP76 activation in human primary T cells.
A model for CAR T signaling pathway
Our data reveal that CAR exhibits differences in its signaling mechanism from TCR. LAT plays a crucial role in signaling after TCR engagement. Tyrosine-phosphorylated LAT recruits several molecules, including Grb2, PLC1, and Gads, which promote microcluster formation.
Microclusters further transduce signal to downstream pathways that promote synapse formation and cytokine production ( Figure 5A) . In contrast, when CAR is engaged, it can induce microcluster formation even in the absence of LAT. CAR could directly recruit LAT binding partner Gads, to trigger downstream signaling that leads to actin remodeling and immunological synapse formation. However, LAT is still partially required for CAR-induced cytokine production ( Figure   5B ).
The discovery of a LAT-independent signaling pathway may be related to and provide an explanation for previous reports showing that CAR triggers faster proximal signaling and faster killing of target cells than TCR 6 . CAR could take a shortcut to bypass LAT, and directly recruit downstream signaling proteins Grb2, Gads, and PLC1 to transduce signaling. The multivalent interactions between CAR and SH2 domain-containing adaptor proteins might drive the formation of CAR microclusters, even in the absence of LAT. However, additional work will be needed to dissect more details on the LAT-independent signaling and how that changes the overall kinetics of the CAR T cell signaling response. 
Methods
Key Resources
Lentiviral Product and Generation of Stable Expressing Jurkat Cell Lines
HEK293T cells were co-transfected with the pHR transfer plasmids with second generation packaging plasmids pMD2.G and psPAX2 (Addgene plasmid #12259 and #12260) using
Lipofectamine LTX Reagent (ThermoFisher). 48 hr after plasmid transfection, cell culture media containing virus particles were harvested, centrifuged and filtered through 0.45 µm pore size filter, and mixed with Jurkat cells for infection in RPMI media for 72 hr. Jurkat cells expressing fluorescent proteins were FACS sorted to generate a stable and homogenous expression population.
Primary T Cell Gene Editing
T cell editing was performed according to published protocols 21, 22 . Briefly, peripheral blood 
Preparation of Supported Lipid Bilayer
Lipid mixture were prepared with 97.5% POPC, 2.0% DGS-NGA-Ni, 0.5% PEG5000-PE, and less than 0.1% Biotin-Cap-PE. Lipids were dissolved in chloroform in glass tubes, and dried under a stream of argon gas followed by further drying in the vacuum for 2 hr. The dried lipid films were then hydrated with PBS pH 7.4 (invitrogen). The small unilamellar vesicles (SUVs) were produced by twenty freeze-thaw cycles (-80ºC and 37ºC) and collected as the supernatant after centrifuge at 53,000x g for 45 min at 4ºC. SUVs were stored at 4ºC and used within 2 weeks. 
IL-2 Production
Raji B cells were co-cultured at a 1:1 ratio with Jurkat CAR T cells in RPMI medium supplemented with 20 mM HEPES-Na + , pH7.4 for 24 hours at 37ºC. Supernatant was collected for IL-2 measurement using an ELISA kit (BioLegend #431801).
Cell Conjugation Assay
Raji B or K562 cells expressing a membrane marker mCherry-CAAX were co-cultured at a 1:1 ratio with Jurkat CAR T cells in RPMI medium supplemented with 20 mM HEPES-Na + , pH7.4 for 1 hr at 37ºC. Cells were fixed in 1.6% paraformaldehyde for 15 min at RT, washed, and resuspended in RPMI medium supplemented with 20 mM HEPES and imaged by confocal microscopy.
Imaging Setup
Imaging was performed on a Nikon TI-E microscope equipped with a Nikon 100× Plan Apo 
Image Analysis
Images were analyzed using Fiji. The same brightness and contrast were applied to images within the same panels. To quantify the clustering levels (as shown in Figure 2B and 3B), a uniform cellsized circular region of interest (ROI) that is of 10 µm in diameter was manually placed over the region of cell fluorescence. The average and the standard deviation of fluorescence intensity inside the ROI was measured respectively, and the normalized variance, i.e. the ratio of the standard deviation fluorescence intensity divided by the average fluorescence intensity, was used to indicate the dispersive distribution of fluorescence intensity for each cell. To quantify pSLP76 levels by immunofluorescence ( Figure 3B and 4C) or Gads recruitment ( Figure 3A) , a uniform cell-sized circular ROI that is of 10 µm in diameter was manually placed over the region of cell fluorescence, and the fluorescence intensity of the channel of interest inside that ROI was measured.
Immunoblotting
Cells were washed twice in cold PBS and lysed on ice for 15 min in lysis buffer containing 50 mM Tris, 150 mM NaCl, 0.1% (w/v) SDS, 0.5% (w/v) sodium deoxycholate, 1% (v/v) TritonX-100, pH 7.5 supplemented with protease inhibitor cocktail (Roche) and benzonase (Novagen). Cell lysates were then centrifuged at 21,000 xg for 20 min at 4°C. The supernatants were processed for SDS-PAGE and immunoblotting with standard procedure. Immunoblots were visualized using Odyssey Fc Imager (LI-COR Biosciences) at 800 nm channel, and quantified using the gel analysis function in Fiji.
Immunofluorescence
Cells were activated on supported lipid bilayers in the imaging buffer (see section "Imaging Setup" for formula) for 30 min at 37ºC, and fixed by adding PFA to a final concentration of 3.2% (v/v) and incubating at room temperature for 15 min. Cells were then washed twice with PBS, permeabilized with methanol at 4ºC for 10 min. Then cells were blocked with PBS containing 0.1% (v/v) tween20, 1% (w/v) BSA, and 22.5 mg/mL glycine for one hour, and incubated with the primary antibody in the same buffer overnight. The next day, cells were washed three times with PBS, incubated with buffer containing Alexa-647 conjugated secondary antibody for 1 hour. Excess antibodies were washed away before proceeding to image acquisition.
